Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TBC1D3F | CTRPv2 | pan-cancer | AAC | -0.36 | 0.0009 |
mRNA | CMYA5 | CTRPv2 | pan-cancer | AAC | -0.41 | 0.0009 |
mRNA | BUB1B | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0009 |
mRNA | SPAST | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0009 |
mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.38 | 0.0009 |
mRNA | RND3 | CTRPv2 | pan-cancer | AAC | -0.43 | 0.0009 |
mRNA | GLB1L | CTRPv2 | pan-cancer | AAC | -0.37 | 0.0009 |
mRNA | ECM1 | CTRPv2 | pan-cancer | AAC | -0.43 | 0.0009 |
mRNA | SCYL1 | CTRPv2 | pan-cancer | AAC | -0.42 | 0.0009 |
mRNA | PNPT1 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0009 |